Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free PYC Stock Alerts

Physiomics (PYC) Competitors

Physiomics logo
GBX 0.42 -0.03 (-5.62%)
As of 08/12/2026 11:37 AM Eastern
Compare

PYC vs. OBD, TLM, BNR, NFX, and MTFB

Should you buy Physiomics stock or one of its competitors? Physiomics's main competitors and comparable companies include Oxford BioDynamics (OBD), Talisman Metals (TLM), Burning Rock Biotech (BNR), Nuformix (NFX), and Motif Bio (MTFB). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Physiomics compare to Oxford BioDynamics?

Oxford BioDynamics (LON:OBD) and Physiomics (LON:PYC) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk, analyst recommendations and media sentiment.

Oxford BioDynamics has a beta of 0.42, suggesting that its share price is 58% less volatile than the broader market. Comparatively, Physiomics has a beta of 1.05, suggesting that its share price is 5% more volatile than the broader market.

11.6% of Oxford BioDynamics shares are held by institutional investors. Comparatively, 0.8% of Physiomics shares are held by institutional investors. 15.6% of Oxford BioDynamics shares are held by insiders. Comparatively, 20.7% of Physiomics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Physiomics has lower revenue, but higher earnings than Oxford BioDynamics. Physiomics is trading at a lower price-to-earnings ratio than Oxford BioDynamics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oxford BioDynamics£1.20M4.85-£103.52M-£0.20N/A
Physiomics£953.01K2.00-£922.82K-£0.15N/A

Physiomics has a net margin of -50.92% compared to Oxford BioDynamics' net margin of -825.61%. Physiomics' return on equity of -89.43% beat Oxford BioDynamics' return on equity.

Company Net Margins Return on Equity Return on Assets
Oxford BioDynamics-825.61% -451.74% -56.23%
Physiomics -50.92%-89.43%-76.38%

In the previous week, Oxford BioDynamics had 1 more articles in the media than Physiomics. MarketBeat recorded 1 mentions for Oxford BioDynamics and 0 mentions for Physiomics. Oxford BioDynamics' average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.

Company Overall Sentiment
Oxford BioDynamics Neutral
Physiomics Neutral

Summary

Oxford BioDynamics and Physiomics tied by winning 6 of the 12 factors compared between the two stocks.

How does Physiomics compare to Talisman Metals?

Physiomics (LON:PYC) and Talisman Metals (LON:TLM) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, risk, media sentiment and profitability.

Talisman Metals has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Talisman Metals' return on equity of -32.71% beat Physiomics' return on equity.

Company Net Margins Return on Equity Return on Assets
Physiomics-50.92% -89.43% -76.38%
Talisman Metals N/A -32.71%3.70%

In the previous week, Talisman Metals had 1 more articles in the media than Physiomics. MarketBeat recorded 1 mentions for Talisman Metals and 0 mentions for Physiomics. Talisman Metals' average media sentiment score of 0.21 beat Physiomics' score of 0.00 indicating that Talisman Metals is being referred to more favorably in the news media.

Company Overall Sentiment
Physiomics Neutral
Talisman Metals Neutral

Physiomics has higher revenue and earnings than Talisman Metals. Physiomics is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Physiomics£953.01K2.00-£922.82K-£0.15N/A
Talisman MetalsN/AN/A-£1.35M£12.390.51

0.8% of Physiomics shares are owned by institutional investors. Comparatively, 1.4% of Talisman Metals shares are owned by institutional investors. 20.7% of Physiomics shares are owned by company insiders. Comparatively, 95.2% of Talisman Metals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Physiomics has a beta of 1.05, suggesting that its share price is 5% more volatile than the broader market. Comparatively, Talisman Metals has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market.

Summary

Talisman Metals beats Physiomics on 9 of the 12 factors compared between the two stocks.

How does Physiomics compare to Burning Rock Biotech?

Burning Rock Biotech (LON:BNR) and Physiomics (LON:PYC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends.

0.8% of Physiomics shares are held by institutional investors. 20.7% of Physiomics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Burning Rock Biotech has higher earnings, but lower revenue than Physiomics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Burning Rock BiotechN/AN/AN/AN/AN/A
Physiomics£953.01K2.00-£922.82K-£0.15N/A

In the previous week, Burning Rock Biotech's average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.

Company Overall Sentiment
Burning Rock Biotech Neutral
Physiomics Neutral

Burning Rock Biotech has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Burning Rock Biotech's return on equity of 0.00% beat Physiomics' return on equity.

Company Net Margins Return on Equity Return on Assets
Burning Rock BiotechN/A N/A N/A
Physiomics -50.92%-89.43%-76.38%

Summary

Burning Rock Biotech and Physiomics tied by winning 3 of the 6 factors compared between the two stocks.

How does Physiomics compare to Nuformix?

Physiomics (LON:PYC) and Nuformix (LON:NFX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.

In the previous week, Physiomics' average media sentiment score of 0.00 equaled Nuformix'saverage media sentiment score.

Company Overall Sentiment
Physiomics Neutral
Nuformix Neutral

Nuformix has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Nuformix's return on equity of -83.53% beat Physiomics' return on equity.

Company Net Margins Return on Equity Return on Assets
Physiomics-50.92% -89.43% -76.38%
Nuformix N/A -83.53%-17.20%

0.8% of Physiomics shares are owned by institutional investors. Comparatively, 0.1% of Nuformix shares are owned by institutional investors. 20.7% of Physiomics shares are owned by company insiders. Comparatively, 7.5% of Nuformix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Nuformix has lower revenue, but higher earnings than Physiomics. Nuformix is trading at a lower price-to-earnings ratio than Physiomics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Physiomics£953.01K2.00-£922.82K-£0.15N/A
NuformixN/AN/A-£383.40K-£0.03N/A

Physiomics has a beta of 1.05, indicating that its share price is 5% more volatile than the broader market. Comparatively, Nuformix has a beta of 1.519, indicating that its share price is 52% more volatile than the broader market.

Summary

Nuformix beats Physiomics on 6 of the 10 factors compared between the two stocks.

How does Physiomics compare to Motif Bio?

Physiomics (LON:PYC) and Motif Bio (LON:MTFB) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership.

In the previous week, Physiomics' average media sentiment score of 0.00 equaled Motif Bio'saverage media sentiment score.

Company Overall Sentiment
Physiomics Neutral
Motif Bio Neutral

0.8% of Physiomics shares are owned by institutional investors. 20.7% of Physiomics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Motif Bio has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Motif Bio's return on equity of 0.00% beat Physiomics' return on equity.

Company Net Margins Return on Equity Return on Assets
Physiomics-50.92% -89.43% -76.38%
Motif Bio N/A N/A N/A

Motif Bio has lower revenue, but higher earnings than Physiomics. Physiomics is trading at a lower price-to-earnings ratio than Motif Bio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Physiomics£953.01K2.00-£922.82K-£0.15N/A
Motif BioN/AN/AN/A-£19.20N/A

Summary

Physiomics and Motif Bio tied by winning 4 of the 8 factors compared between the two stocks.

Get Physiomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PYC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PYC vs. The Competition

Export
MetricPhysiomicsBiotechnology IndustryHealthcare SectorLON Exchange
Market Cap£1.90M£3.74B£7.08B£2.89B
Dividend Yield6.20%3.76%2.58%6.09%
P/E Ratio-2.8010.36268.54368.57
Price / Sales2.001,270.17651.2083,659.40
Price / Cash4.21102.9470.5927.89
Price / Book2.0117.8113.117.22
Net Income-£922.82K-£13.23M£3.45B£5.89B
7 Day Performance-2.33%2.97%1.81%1.34%
1 Month Performance-18.60%1.40%0.90%2.83%
1 Year Performance-4.11%55.32%67.67%70.18%

Physiomics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PYC
Physiomics
N/AGBX 0.42
-5.6%		N/A+1.4%£1.90M£953.01KN/A10
OBD
Oxford BioDynamics
N/AGBX 0.11
+1.0%		N/A-62.7%£4.55M£1.20MN/A45
TLM
Talisman Metals
N/AGBX 6
-4.0%		N/AN/A£3.85MN/A0.485
BNR
Burning Rock Biotech
N/AN/AN/AN/A£3.77MN/AN/A1,390
NFX
Nuformix
N/AGBX 0.14
-11.8%		N/A+55.4%£3.71MN/AN/A3

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:PYC) was last updated on 8/13/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
What's the Best Way to Lower RMD Taxes?
Once you turn 73, the IRS requires you to take distributions from your IRA, 401(k), and other retirement accou...
SmartAsset | Sponsoredtc pixel